Treating localised prostate cancer with transperineal brachytherapy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 252, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment

By Resnick Matthew J.   Barocas Daniel A.   Morgans Alicia K.   Phillips Sharon E.   Chen Vivien W.   Cooperberg Matthew R.   Goodman Michael   Greenfield Sheldon   Hamilton Ann S.   Hoffman Karen E.   Kaplan Sherri H.   Paddock Lisa E.   Stroup Antoinette M.   Wu Xiao-Cheng   Koyama Tatsuki   Penson David F.  

Cancer, Vol. 120, Iss. 8, 2014-04 ,pp. : 1263-1271

Blackwell Publishing

Access to resources Recommend Favorite

The rise and fall of prostate brachytherapy: Use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base

By Martin Jeffrey M.   Handorf Elizabeth A.   Kutikov Alexander   Uzzo Robert G.   Bekelman Justin E.   Horwitz Eric M.   Smaldone Marc C.  

Cancer, Vol. 120, Iss. 14, 2014-07 ,pp. : 2114-2121

Blackwell Publishing

Access to resources Recommend Favorite

Prostate Brachytherapy: An Option in the Treatment of Early Stage Prostate Cancer

By Glegg M.   Dodds D.   Baxter G.M.  

UroOncology, Vol. 4, Iss. 2, 2004-06 ,pp. : 53-69

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Role of Androgen Ablation with Low-Dose-Rate Brachytherapy in the Treatment of Prostate Cancer

By Jani Ashesh B.   Shoushtari Asal   Feinstein Jeffrey M.  

Clinical Drug Investigation, Vol. 26, Iss. 12, 2006-01 ,pp. : 723-731

Adis International

Access to resources Recommend Favorite